Molecular Analysis of East African Lumpy Skin Disease Viruses Reveals a Mixed Isolate with Features of Both Vaccine and Field Isolates.
B22R gene
EEV glycoprotein
GPCR gene
LSDV
RPO30 gene
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
26 May 2021
26 May 2021
Historique:
received:
31
03
2021
revised:
15
05
2021
accepted:
20
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Lumpy skin disease (LSD), an economically significant disease in cattle caused by lumpy skin disease virus (LSDV), is endemic to nearly all of Africa. Since 2012, LSDV has emerged as a significant epizootic pathogen given its rapid spread into new geographical locations outside Africa, including the Middle East, Eastern Europe, and Asia. To assess the genetic diversity of LSDVs in East Africa, we sequenced and analyzed the RPO30 and GPCR genes of LSDV in twenty-two archive samples collected in Ethiopia, Kenya, and Sudan before the appearance of LSD in the Middle East and its incursion into Europe. We compared them to publicly available sequences of LSDVs from the same region and those collected elsewhere. The results showed that the East African field isolates in this study were remarkably similar to each other and to previously sequenced field isolates of LSDV for the RPO30 and GPCR genes. The only exception was LSDV Embu/B338/2011, a field virus collected in Kenya, which displayed mixed features between the LSDV Neethling vaccine and field isolates. LSDV Embu/B338/2011 had the same 12-nucleotide insertion found in LSDV Neethling and KS-1 vaccines. Further analysis of the partial EEV glycoprotein, B22R, RNA helicase, virion core protein, NTPase, and N1R/p28-like protein genes showed that LSDV Embu/B338/2011 differs from previously described LSDV variants carrying the 12-nucleotide insertion in the GPCR gene. These findings highlight the importance of the constant monitoring of genetic variation among LSDV isolates.
Identifiants
pubmed: 34073392
pii: microorganisms9061142
doi: 10.3390/microorganisms9061142
pmc: PMC8229927
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Gen Virol. 2009 Aug;90(Pt 8):1967-1977
pubmed: 19339476
Transbound Emerg Dis. 2016 Apr;63(2):e213-9
pubmed: 25098267
J Gen Virol. 1989 Feb;70 ( Pt 2):485-9
pubmed: 2543750
Transbound Emerg Dis. 2018 Feb;65(1):240-243
pubmed: 28239954
Arch Virol. 2019 Jun;164(6):1575-1585
pubmed: 30949814
J Hyg (Lond). 1976 Apr;76(2):163-71
pubmed: 177699
Transbound Emerg Dis. 2021 May;68(3):977-980
pubmed: 33548101
Transbound Emerg Dis. 2012 Feb;59(1):40-8
pubmed: 21749675
Antiviral Res. 2014 Sep;109:1-6
pubmed: 24973760
J Virol. 2001 Aug;75(15):7122-30
pubmed: 11435593
Transbound Emerg Dis. 2020 Nov;67(6):2946-2960
pubmed: 32506755
Vet Rec. 1994 Oct 1;135(14):330-2
pubmed: 7825272
PLoS One. 2018 Dec 12;13(12):e0207480
pubmed: 30540759
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Rev Elev Med Vet Pays Trop. 1984;37(4):395-9
pubmed: 6545834
BMC Vet Res. 2021 Jan 29;17(1):61
pubmed: 33514360
PLoS One. 2020 May 13;15(5):e0232584
pubmed: 32401805
Transbound Emerg Dis. 2008 Sep;55(7):263-72
pubmed: 18774991
Antiviral Res. 2015 Jul;119:28-35
pubmed: 25907637
Transbound Emerg Dis. 2020 Nov;67(6):2408-2422
pubmed: 32304275
Br Vet J. 1977 Mar-Apr;133(2):184-9
pubmed: 608058
Mol Biol Evol. 2012 Aug;29(8):1969-73
pubmed: 22367748
J Virol Methods. 2016 Jun;232:12-5
pubmed: 26902159
Vet Microbiol. 2011 Apr 21;149(1-2):30-9
pubmed: 21115310
Vet Microbiol. 2017 Mar;201:78-84
pubmed: 28284627
Front Vet Sci. 2016 Mar 03;3:19
pubmed: 26973845
Transbound Emerg Dis. 2021 Mar;68(2):216-219
pubmed: 33119963
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Sci Rep. 2019 Apr 30;9(1):6646
pubmed: 31040355